Comorbidity and comedication burden among people living with HIV in the United States

References

• Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2018. HIV Surveillance Report. p. 31 [Internet]. 2020 [cited 2021 Oct 14]. Available from: https://www.cdc.gov/hiv/libary/reports/hiv-surveillance/vol-31/index.html
   Google Scholar
• O’Keefe KJ, Scheer S, Chen M-J, et al. People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010. AIDS Care. 2013;25(9):1145–1148.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. HIV among people aged 50 and older. 2018 [cited 2021 Oct 14]. Available from: https://www.cdc.gov/hiv/group/age/olderamericans/index.html
   Google Scholar
• Cahill S, Valadéz R. Growing older with HIV/AIDS: new public health challenges. Am J Public Health. 2013;103(3):e7–e15.
   PubMed Web of Science ®Google Scholar
• Lewden C, Bouteloup V, De Wit S, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥ 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433–445.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–1126.
   PubMed Web of Science ®Google Scholar
• Williams ND, Huser V, Rhame R, et al. The changing patterns of comorbidities associated with human immunodeficiency virus infection, a longitudinal retrospective cohort study of Medicare patients. Medicine. 2021;100(16):e25428.
   PubMed Web of Science ®Google Scholar
• Gallant J, Hsue PY, Shreay S, et al. Comorbidities among US patients with prevalent HIV infection—a trend analysis. J Infect Dis. 2017;216:1525–1533.
   PubMed Web of Science ®Google Scholar
• Priest JL, Burton T, Blauer-Peterson C, et al. Clinical characteristics and treatment patters among US patients with HIV. Am J Manag Care. 2019;25(12):580–586.
   PubMed Web of Science ®Google Scholar
• US Department Commerce Economics and Statistics Administration. Census Regions and Divisions of the United States [Internet] [cited 2021 Oct 14]. Available from: https://www2.census.gov/programs-surveys/sahie/reference-maps/2017/us-regdiv.pdf
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Kong AM, Pozen A, Anastos K, et al. Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United States: a retrospective claims-based analysis. AIDS Patient Care STDS. 2019;33(3):93–103.
   PubMed Web of Science ®Google Scholar
• Hernandez-Romieu AC, Garg S, Rosenberg ES, et al. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diabetes Res Care. 2017;5(1):e000304.
   PubMed Web of Science ®Google Scholar
• Friedman EE, Duffus WA. Chronic health conditions in Medicare beneficiaries 65 years old, and older with HIV infection. AIDS. 2016;30(16):2529–2536.
   PubMed Web of Science ®Google Scholar
• Do AN, Rosenberg ES, Sullivan PS, et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One. 2014;9(3):e92842.
   PubMed Web of Science ®Google Scholar
• Kolakowska A, Maresca AF, Collins IJ, et al. Update on adverse effects of HIV integrase inhibitors. Curr Treat Options Infect Dis. 2019;11(4):372–387.
   PubMedGoogle Scholar
• Guaraldi G, Prakash M, Moecklinghoff C, et al. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev. 2014;16(2):75–89.
   PubMed Web of Science ®Google Scholar
• Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35(21):1373–1381.
   PubMed Web of Science ®Google Scholar
• Islam FM, Wu J, Jansson J, et al. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health. 2012;12:234.
   PubMed Web of Science ®Google Scholar
• Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17):2165–2174.
   PubMed Web of Science ®Google Scholar
• Triant VA, Brown TT, Lee H, et al. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008;93(9):3499–3504.
   PubMed Web of Science ®Google Scholar
• Babu H, Ambikan AT, Gabriel EE, et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol. 2019;10:1965.
   PubMed Web of Science ®Google Scholar
• Lv T, Cao W, Li T. HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456. eCollection 2021.
   PubMedGoogle Scholar
• Greene M, Steinman MA, McNicholl IR, et al. Polypharmacy, drug–drug interactions and potentially inappropriate medications in older HIV-infected adults. J Am Geriatr Soc. 2014;62(3):447–453.
   PubMed Web of Science ®Google Scholar
• McNicholl IR, Gandhi M, Hare CB, et al. A pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients. Pharmacotherapy. 2017;37(12):1498–1506.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Malagoli A, Calcagno A, et al. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years. BMC Geriatr. 2018;18(1):99.
   PubMed Web of Science ®Google Scholar
• Emmons RP, Hastain NV, Miano TA, et al. Patients with HIV are less likely to receive appropriate statin therapy for cardiovascular disease risk reduction. J Pharm Pract. 2022;35(4):568–572.
   PubMed Web of Science ®Google Scholar
• Murray MM, Lin J, Stein AB, et al. Relationship of polypharmacy to HIV RNA suppression in people aged ≥50 years living with HIV. HIV Med. 2021;22(8):742–749.
   PubMed Web of Science ®Google Scholar
• Jernigan MG, Kipp GM, Rather A, et al. Clinical implications and management of drug–drug interactions between antiretroviral agents and psychotropic medications. Ment Health Clin. 2013;2(9):274–285.
   Google Scholar
• Sabourin AA, Patel T, Saad S, et al. Management of anticoagulation in patients with human immunodeficiency virus/acquired immunodeficiency virus. Thromb Res. 2021;200:102–108.
   PubMed Web of Science ®Google Scholar